Dublin, Sept. 21, 2018 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Market Research Report 2018" report has been added to ResearchAndMarkets.com's offering.
Global Neuromodulation market is set to surpass US$ 7 Billion by 2025
With such an extensive therapeutic scope and immense ongoing enhancements in biotechnology, neuromodulation will likely be a leading growth industry over the forecast period. The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, an aging population, technological advances and deal-making activity globally.
The report titled Global Neuromodulation Market Research Report 2018 examines the market dynamics, competitive landscape and discusses major trends. The study describes an in-depth analysis of the Global Neuromodulation Market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as application, technology, geography, company, and competitive landscape. A comprehensive analysis has been done on market share of all the categories. Key trends in terms of merger & acquisitions, collaborations, partnerships, and agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Neuromodulation market.
The report concludes with the profiles of major players in the Neuromodulation market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and the recent development of the Neuromodulation market.
Further key findings from the report suggest:
- North America is the most attractive market in the neuromodulation market
- Chronic pain is the major application segment of the neuromodulation market
- With regard to technology, spinal cord stimulation represents the largest segment of the neuromodulation market
- The APAC marketplace is slated to grow at the highest rate, and China, India, and Japan will be major igniters
Market Segmentation: Global Neuromodulation Market
The global neuromodulation market has been segmented on the basis of technology, application, geography and company
Neuromodulation Market, by Technology
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Sacral Nerve Stimulation (SNS)
- Vagus Nerve Stimulation (VNS)
- Other Technologies
Neuromodulation Market, by Application
- Chronic Pain
- Parkinson's Disease
- Urinary Fecal Incontinence
- Refractory Epilepsy
- Essential Tremor
- Dystonia
- Gastroparesis
- Treatment-Resistant Depression (TRD)
- Obsessive Compulsive Disorder (OCD)
- Other Applications
Neuromodulation Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Rest of the World (ROW)
Neuromodulation Market, by Company
- Medtronic
- Boston Scientific
- St. Jude Medical (Abbott)
- LivaNova
- Nevro
Key Topics Covered:
1. Executive Summary
2. Global Neuromodulation Market Analysis & Forecast (2013 - 2025)
3. Market Share Analysis of Neuromodulation Market (%),2017
3.1 Global Neuromodulation Market Share, By Technology
3.2 Global Neuromodulation Market Share, By Region
3.3 Global Neuromodulation Market Share, By Application
3.4 Global Neuromodulation Market Share, By Company
4. Key Market Drivers and Inhibitors of the Neuromodulation Market
4.1 Market Drivers
4.2 Market Inhibitors
5. Global Neuromodulation Market Size & Forecast, By Technology (2013 - 2025)
5.1 Spinal Cord Stimulation
5.2 Deep Brain Stimulation
5.3 Sacral Nerve Stimulation
5.4 Vagus Nerve Stimulation
5.5 Other Technologies
6. Global Neuromodulation Market Size & Forecast, By Region (2013 - 2025)
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Latin America
6.5 Rest of the World (ROW)
7. Global Neuromodulation Market Size & Forecast, By Application (2013 - 2025)
7.1 Chronic Pain
7.2 Parkinson's Disease
7.3 Urinary Fecal Incontinence (UFI)
7.4 Refractory Epilepsy
7.5 Essential Tremor
7.6 Dystonia
7.7 Gastroparesis
7.8 Treatment-Resistant Depression (TRD)
7.9 Obsessive Compulsive Disorder (OCD)
7.10 Other Application
8. Major Deals in the Neuromodulation Market
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
9. Key Companies Analysis
- Boston Scientific
- LivaNova
- Medtronic
- Nevro
- St. Jude Medical (Abbott)
For more information about this report visit https://www.researchandmarkets.com/research/zpgwtp/global?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.